U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07532902) titled 'A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer' on April 08.
Brief Summary: The researchers are doing this study to test the safety of BMS-986504 in combination with standard disease-specific anticancer medication in people with metastatic/advanced unresectable MTAP-deleted solid tumor cancer.
Study Start Date: April 07
Study Type: INTERVENTIONAL
Condition:
Diffuse Pleural Mesothelioma
Gastroesophageal Carcinoma
Urothelial Carcinoma
Intervention:
DRUG: BMS-986504
BMS-986504 PO daily
DRUG: Ipilimumab
Ipilimumab (1mg/kg Q6wk)
DRUG: Nivolumab
Nivolumab (360mg flat dose Q3wk)
DRUG: 5-...